Bringing Medicines for HIV Prevention to a Family Planning Clinic
NCT06930508
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to understand what patients and physicians think about providing medications to prevent HIV transmission to patients in a family planning clinic. These medications are known as pre-exposure prophylaxis, or PrEP. The main questions to answer are: Do patients find it acceptable to be asked about, and offered, PrEP during their visit to a family planning clinic? What things make it easier or harder to ask about PrEP in a family planning clinic setting? What things make it easier or harder to begin PrEP in a family planning clinic setting?
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- HIV
- PrEP
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 16 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Women and Infants Hospital of Rhode Island
- Last updated on ClinicalTrials.gov
- August 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Rhode Island · 1
- Women and Infants Hospital of Rhode Island · Providence, RI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.